Loading…
Semnur, a majority-owned subsidiary of Scilex Holding Co, announced the agreement.
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) announced on July 07, 2026 Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP.
The announcement cited $100,000,000, $10.00 per share, and 10,000,000 shares. Share consideration (payable in the issuer's shares): 10,000,000 shares.
Scilex Holding Co has a free float of 7,000,542 shares and 8,491,267 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.